Ensysce Biosciences, Inc. ENSC 深 沪
已收盘 04-02 16:00:00 美东时间
0.6096
+0.063
+11.44%
华盛通- 最 高0.61
- 今 开0.5367
- 成交量 23.28万股
- 最 低 0.5201
- 昨 收 0.547
- 总市值 565.58万
- 52周最高 4.85
- 市盈率 静 --
- 换手率 2.51%
- 52周最低 0.3144
- 委 比 21.15%
- 总股本 927.78万
- 历史最高 61632.00
- 量 比 0.85
- 振 幅 16.44%
- 历史最低 0.3144
- 每 手 1
- 风险率 0.73%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Watching Ensysce Biosciences; Zacks Small-Cap Research Gives Stock $16.45 Price Valuation, Says "Earnings Release Show Positive Momentum"
https://s27.q4cdn.com/906368049/files/News/2026/Zacks_SCR_Research_03312026_ENSC_Sorensen.pdf
03-31 23:06
Ensysce Biosciences Q4 EPS $(0.75) Misses $(0.70) Estimate, Sales $1.882M Beat $500.000K Estimate
Ensysce Biosciences (NASDAQ:ENSC) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.70) by 7.14 percent. This is a 74.14 percent increase over losses of $(2.90) per share
03-31 05:24
Ensysce Biosciences Publishes First Clinical Manuscript On Multi-Pill Abuse Resistance Overdose Protection Technology
Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company pioneering next-generation pain and central nervous system therapeutics designed to minimize risk of abuse and
03-03 21:03
10 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Icecure Medical (NASDAQ:ICCM) shares moved upwards by 17.7% to $0.68 d...
03-02 20:05
Tiny Pain-Focused Biotech Ensysce Biosciences Surges Amid Strategic Review
Ensysce Biosciences stock surged 58% after launching a strategic review to explore partnerships, licensing deals, or asset sales.
02-28 01:10
Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 33%; Here Are 20 Stocks Moving Premarket
Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) rose sharply in pre-market t...
02-23 17:57
Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket
Shares of Credo Technology Group Holding Ltd (NASDAQ:CRDO) rose sharply in pre-...
02-10 17:45
Ensysce Biosciences Receives Notice Of Allowance From Brazilian Patent Office For Issuance Of Patent For Additional Opioid Families For Company's Trypsin Activated Abuse Protection, Multi-Pill Abuse Resistance Technologies
Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for novel therapeutics while reducing the potential for abuse and overdose,
01-21 21:09
Ensysce Biosciences Receives European Patent Allowance For PF8026, Novel ADHD Prodrug With TAAP And MPAR Abuse‑Deterrent Technologies
~ New ADHD pipeline leverages TAAP™ and MPAR® technologies to improve safety for patients ~SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 8, 2026 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the
01-08 21:06
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Athira Pharma (NASDAQ:ATHA) stock increased by 30.6% to $5.4 during Th...
2025-12-18 20:05
